These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37572540)

  • 1. Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine.
    Pöysti S; Silojärvi S; Brodnicki TC; Catterall T; Liu X; Mackin L; Luster AD; Kay TWH; Christen U; Thomas HE; Hänninen A
    J Autoimmun; 2023 Nov; 140():103090. PubMed ID: 37572540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets.
    Hu C; Ding H; Li Y; Pearson JA; Zhang X; Flavell RA; Wong FS; Wen L
    Proc Natl Acad Sci U S A; 2015 Sep; 112(36):11318-23. PubMed ID: 26305961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
    Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
    PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes.
    Nigi L; Brusco N; Grieco GE; Licata G; Krogvold L; Marselli L; Gysemans C; Overbergh L; Marchetti P; Mathieu C; Dahl Jørgensen K; Sebastiani G; Dotta F
    Front Endocrinol (Lausanne); 2020; 11():630. PubMed ID: 33042009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis.
    Morimoto J; Yoneyama H; Shimada A; Shigihara T; Yamada S; Oikawa Y; Matsushima K; Saruta T; Narumi S
    J Immunol; 2004 Dec; 173(11):7017-24. PubMed ID: 15557199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet inflammation and CXCL10 in recent-onset type 1 diabetes.
    Roep BO; Kleijwegt FS; van Halteren AG; Bonato V; Boggi U; Vendrame F; Marchetti P; Dotta F
    Clin Exp Immunol; 2010 Mar; 159(3):338-43. PubMed ID: 20059481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice.
    Akazawa S; Mackin L; Jhala G; Fynch S; Catterall T; Selck C; Graham KL; Krishnamurthy B; Pappas EG; Kwong CJ; Sutherland APR; Kay TWH; Brodnicki TC; Thomas HE
    Diabetologia; 2021 Apr; 64(4):878-889. PubMed ID: 33483762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice.
    Cardozo AK; Proost P; Gysemans C; Chen MC; Mathieu C; Eizirik DL
    Diabetologia; 2003 Feb; 46(2):255-66. PubMed ID: 12627325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceleration of diabetes development in CXC chemokine receptor 3 (CXCR3)-deficient NOD mice.
    Yamada Y; Okubo Y; Shimada A; Oikawa Y; Yamada S; Narumi S; Matsushima K; Itoh H
    Diabetologia; 2012 Aug; 55(8):2238-45. PubMed ID: 22487925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes.
    Osum KC; Burrack AL; Martinov T; Sahli NL; Mitchell JS; Tucker CG; Pauken KE; Papas K; Appakalai B; Spanier JA; Fife BT
    Sci Rep; 2018 May; 8(1):8295. PubMed ID: 29844327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.
    Christen U; Kimmel R
    Front Endocrinol (Lausanne); 2020; 11():591083. PubMed ID: 33193102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes.
    Uno S; Imagawa A; Saisho K; Okita K; Iwahashi H; Hanafusa T; Shimomura I
    Endocr J; 2010; 57(11):991-6. PubMed ID: 20966598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in macrophages and T cells: relevance for arthritis.
    Lee JH; Kim B; Jin WJ; Kim HH; Ha H; Lee ZH
    Arthritis Res Ther; 2017 Jul; 19(1):163. PubMed ID: 28724396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes.
    Tanaka S; Nishida Y; Aida K; Maruyama T; Shimada A; Suzuki M; Shimura H; Takizawa S; Takahashi M; Akiyama D; Arai-Yamashita S; Furuya F; Kawaguchi A; Kaneshige M; Katoh R; Endo T; Kobayashi T
    Diabetes; 2009 Oct; 58(10):2285-91. PubMed ID: 19641142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet-Expressed CXCL10 Promotes Autoimmune Destruction of Islet Isografts in Mice With Type 1 Diabetes.
    Bender C; Christen S; Scholich K; Bayer M; Pfeilschifter JM; Hintermann E; Christen U
    Diabetes; 2017 Jan; 66(1):113-126. PubMed ID: 27797910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule CXCR3 antagonist NIBR2130 has only a limited impact on type 1 diabetes in a virus-induced mouse model.
    Christen S; Holdener M; Beerli C; Thoma G; Bayer M; Pfeilschifter JM; Hintermann E; Zerwes HG; Christen U
    Clin Exp Immunol; 2011 Sep; 165(3):318-28. PubMed ID: 21649647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-reactive islet-infiltrating CD8 T cells in NOD mice.
    Mukherjee G; Chaparro RJ; Schloss J; Smith C; Bando CD; DiLorenzo TP
    Immunology; 2015 Apr; 144(4):631-40. PubMed ID: 25333865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet-Resident Memory T Cells Orchestrate the Immunopathogenesis of Type 1 Diabetes through the FABP4-CXCL10 Axis.
    Wu X; Cheong LY; Yuan L; Jin L; Zhang Z; Xiao Y; Zhou Z; Xu A; Hoo RL; Shu L
    Adv Sci (Weinh); 2024 Aug; 11(30):e2308461. PubMed ID: 38884133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD3/Anti-CXCL10 Antibody Combination Therapy Induces a Persistent Remission of Type 1 Diabetes in Two Mouse Models.
    Lasch S; Müller P; Bayer M; Pfeilschifter JM; Luster AD; Hintermann E; Christen U
    Diabetes; 2015 Dec; 64(12):4198-211. PubMed ID: 26293506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL16-dependent scavenging of oxidized lipids by islet macrophages promotes differentiation of pathogenic CD8
    Srivastava N; Hu H; Peterson OJ; Vomund AN; Stremska M; Zaman M; Giri S; Li T; Lichti CF; Zakharov PN; Zhang B; Abumrad NA; Chen YG; Ravichandran KS; Unanue ER; Wan X
    Immunity; 2024 Jul; 57(7):1629-1647.e8. PubMed ID: 38754432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.